본문으로 건너뛰기
← 뒤로

Clinical features and influencing factors analysis of T-cell large granular lymphocytic leukemia complicated with pure red cell aplasia.

1/5 보강
Frontiers in immunology 2025 Vol.16() p. 1695742
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
40 patients with T-LGLL, of whom 15 were classified into the T-LGLL-PRCA group, accounting for one-third of the entire cohort.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Multivariate analysis identified RNC (:0.590; = 0.048) as the sole independent influencing factor ( < 0.05). [CONCLUSION] RNC is an independent influencing factor for the development of T-LGLL-PRCA.

Feng Y, Du Y, Wang Y, Ding Y, Yan J

📝 환자 설명용 한 줄

[OBJECTIVE] This study systematically characterized the key clinical features and influencing factors of patients with T-LGLL-PRCA, aiming to provide evidence to improve clinical diagnostic and therap

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 표본수 (n) 15

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Feng Y, Du Y, et al. (2025). Clinical features and influencing factors analysis of T-cell large granular lymphocytic leukemia complicated with pure red cell aplasia.. Frontiers in immunology, 16, 1695742. https://doi.org/10.3389/fimmu.2025.1695742
MLA Feng Y, et al.. "Clinical features and influencing factors analysis of T-cell large granular lymphocytic leukemia complicated with pure red cell aplasia.." Frontiers in immunology, vol. 16, 2025, pp. 1695742.
PMID 41646969

Abstract

[OBJECTIVE] This study systematically characterized the key clinical features and influencing factors of patients with T-LGLL-PRCA, aiming to provide evidence to improve clinical diagnostic and therapeutic strategies.

[METHODS] Clinical characteristics were retrospectively compared between patients with T-LGLL-PRCA (n=15) and those without PRCA (T-LGLL-Non-PRCA, n=25). Risk factors for the development of T-LGLL-PRCA were evaluated using univariate and multivariate logistic regression analyses.

[RESULTS] This study retrospectively included a total of 40 patients with T-LGLL, of whom 15 were classified into the T-LGLL-PRCA group, accounting for one-third of the entire cohort. The median age of patients in the T-LGLL-PRCA group was 68 years, with a relatively high proportion aged ≥65 years, and the majority were female. The most common symptoms included fatigue, dizziness, and palpitations. The major comorbidity was thrombocytopenia. Positivity for EBV and ANA was frequently observed. Mutations in TET2 exon 11 and exon 3 were the most frequently detected genetic variants. At the molecular level, clonal rearrangements of the TCRβ and TCRγ genes were most commonly observed. Moreover, a substantial proportion of patients displayed a TCR γδ immunophenotype. Significant differences between groups were observed in circulating T-LGL count, Hemoglobin (HB), Hematocrit (HCT), Reticulocyte Count (RNC), Erythropoietin (EPO) levels >750 mIU/mL, and Immature Reticulocyte Fraction (IRF) ( < 0.05). Univariate logistic regression suggested that HB (:0.926;  = 0.003), HCT (:0.837; = 0.006), EPO levels>750 mIU/mL (:7.071; = 0.008), RNC (:0.682; = 0.027), and IRF (:0.857; = 0.007) were associated with T-LGLL-PRCA( < 0.05). Multivariate analysis identified RNC (:0.590; = 0.048) as the sole independent influencing factor ( < 0.05).

[CONCLUSION] RNC is an independent influencing factor for the development of T-LGLL-PRCA.

MeSH Terms

Humans; Female; Male; Red-Cell Aplasia, Pure; Aged; Leukemia, Large Granular Lymphocytic; Middle Aged; Retrospective Studies; Aged, 80 and over; Risk Factors; Adult; Mutation

같은 제1저자의 인용 많은 논문 (5)